Verano Holdings
Top-tier MSO with strong presence in Illinois and New Jersey. Redomiciled from BC to Nevada in Nov 2025.
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
At a composite of 54, Verano Holdings (US Class A) scores as Neutral, with conviction of 2 out of 5 backing the assessment. Weights are locked at 35 percent fundamentals, 25 percent regulatory, 25 percent market, and 15 percent editorial, and each pillar is broken out for direct review. The fundamentals pillar contributes the largest share at 71, pulling the composite into the middle of the band. Opposite that, editorial prints only 30, and is what keeps the rating anchored where it is.
Working through the numbers, Verano Holdings (US Class A) shows reported revenue growth of -0.8 percent year over year, an operating margin of 6.3 percent, a filing cadence of 2 regulator events in the trailing 90 days. Those inputs are the ones that drive the Neutral anchor rather than sentiment. Inputs are limited to primary regulatory filings, licensed fundamentals data, and institutional pricing feeds, plus a density read from CIN newsroom coverage. The rating enables direct comparison across the 336 tickers in the CIN coverage universe on a consistent, deterministic basis, and refreshes on a scheduled cadence tied to the primary-source ingest cycle.
The clearest catalyst is the next quarterly print. Fundamentals contribute 71 of the composite, and either an acceleration in top-line growth or a stabilization of the operating margin would move the score higher; a deterioration on either would compress it.
- IR email
- investors@verano.com
- IR page
- Investor relations
- Headquarters
- 224 W HILL STREET, SUITE 400, CHICAGO, IL, 60610
- Phone
- 312-265-0730
- CEO
- George Archos
- CFO
- Richard Tarapchak
- Auditor
- required
- SEC CIK
- 1848416
- Website
- Company website
- Market cap
- $419.1M
- Enterprise value
- $849.3M
- Price to book
- 0.63
- Price to sales
- 0.51
- EV / EBITDA
- 36.79
- Revenue (TTM)
- $819.9M
- Gross profit (TTM)
- $412.9M
- EBITDA
- $195.8M
- Operating margin
- 6.3%
- Profit margin
- -32.2%
- Rev growth YoY
- -0.8%
- Return on equity
- -32.5%
- Return on assets
- 2.5%
- EPS (TTM)
- $-3.65
- EPS est. current year
- $-0.95
- Wall St. target price
- $25.00
- Shares outstanding
- 73.9M
- Insider ownership
- 14.3%
- Institutional ownership
- 0.3%
- Beta
- 1.40
- Full-time employees
- 3,800
- GICS sector
- Healthcare
- GICS industry
- Drug Manufacturers - Specialty & Generic
- Annual report
- Latest 10-K
- Proxy statement
- Latest DEF 14A
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for Verano Holdings (VRNO)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Verano Holdings (VRNO), a cannabis-sector equity listed on OTCMKTS in the US MSO category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, net loss. (1 bullish signal, 3 bearish signals.)
Top-tier MSO with strong presence in Illinois and New Jersey. Redomiciled from BC to Nevada in Nov 2025.
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for VRNO are maintained by Cannabis Investor News and refreshed throughout the trading day.